Presenter: Shena Vander Ploeg, ND

Original Date: September 23, 2018

With cannabis becoming more mainstream, patients bring lots of questions to clinicians regarding cannabis that many practitioners are left feeling uninformed or unsure of where to start. This presentation offers some perspective to clinicians of how to inform patients of ideas around dosing strategies, methods of consumption, and review of recent research/scientific literature. Dr. Vander Ploeg also covers the development and use of Sativex (outside US) and Epidiolex, which are the pharmaceutical synthetic cannabinoids which have been used internationally in the therapeutic context, and now US has approved Epidiolex.

Pharmaceutical medications to be discussed: Mention: Epidiolex, Sativex (Outside US)

0.5 Pharmacology, 0.5 General (Total 1.0 CEUs) approved by OBNM